Home

Royal Bank of Canada (RY)

159.38
+0.00 (0.00%)
TSX · Last Trade: Apr 22nd, 8:42 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Are Hospital Stocks At Risk Amid Medicaid Funding Fears? RBC Downplays Worries While Retail Eyes Q1 Resultsstocktwits.com
The Wall Street Journal highlighted UHS, THC and HCA as key beneficiaries of Medicaid supplemental payment programs that cost the federal government hundreds of billions.
Via Stocktwits · April 22, 2025
Chipotle Mexican Grill Q1 Preview: Retail Gets Bullish As Traders Eye Tariff Commentary, Expansion Plansstocktwits.com
The burrito chain has maintained that it will not increase the prices of its menu items and will offset higher input costs through automation and other initiatives.
Via Stocktwits · April 22, 2025
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boostinvestors.com
The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly.
Via Investor's Business Daily · April 21, 2025
American Express' Solid Revenue, Spending Trends Drive Analyst Optimismbenzinga.com
RBC analyst maintains Outperform rating on American Express (AXP) with $310 price target. AXP reports strong Q1 2025 results, reaffirms revenue and EPS outlook.
Via Benzinga · April 21, 2025
Looking Into RBC Bearings's Recent Short Interestbenzinga.com
Via Benzinga · April 16, 2025
3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decadefool.com
Consider buying these top-notch AI-powered stocks in the current market dip.
Via The Motley Fool · April 15, 2025
Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With Itinvestors.com
The companies are facing off with their heart drugs in a growing disease area.
Via Investor's Business Daily · April 14, 2025
We Asked Retail Traders Where Tesla's Next 20% Move Is — Most Say ‘Higher’ Despite Growing Short Intereststocktwits.com
Optimists think a bad earnings report is already priced in and hope CEO Elon Musk will soon announce his exit from Trump’s administration.
Via Stocktwits · April 14, 2025
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.investors.com
From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care.
Via Investor's Business Daily · April 10, 2025
Wall Street Analysts Are Slashing Their Stock Market Forecasts. Here's What You Should Do, According to History.fool.com
Via The Motley Fool · April 9, 2025
CorMedix Stock Rises After Preliminary Q1 Results Exceeds Expectations: Retail’s Elatedstocktwits.com
The company expects quarterly adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) to exceed $22.5 million once final numbers are reported, exceeding expectations of $14.78 million.
Via Stocktwits · April 8, 2025
Pacira Biosciences Stock Rises On Patent Litigation Settlement: Retail Sentiment Soarsstocktwits.com
RBC Capital opined that Pacira's settlement of litigation for generic Exparel, which provides some closure to over a year's worth of overhang and uncertainty for shares, is a win for the company and the Exparel franchise.
Via Stocktwits · April 8, 2025
5 Consumer Stocks That Hit 52-Week Lows Last Week On Trump's Tariff Shockwavesstocktwits.com
Retailers and consumer-facing companies are reeling more prominently as they fear the potential hike to consumer prices of their products will directly hurt sales.
Via Stocktwits · April 7, 2025
Woodside Energy In Spotlight After 40% Stake Sale In Louisiana LNG, Retail’s Bullishstocktwits.com
Stonepeak will provide $5.7 billion for the development of Louisiana LNG on an accelerated basis.
Via Stocktwits · April 7, 2025
Badger Meter Gets an Upgrade—2 Stocks That Could Follow
RBC analysts just boosted Badger Meter stock, but the broader theme behind this view might lead investors to other similar opportunities.
Via MarketBeat · April 4, 2025
Chewy Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.fool.com
Via The Motley Fool · April 4, 2025
BlackBerry's QNX, Secure Comms Growth Weighed Down By Tariff Uncertainties, Government Election Shifts: Analystbenzinga.com
RBC Capital Markets analyst maintains BlackBerry with Sector Perform rating, lowers price target to $3.75 due to lower revenue and EBITDA guidance for fiscal 2026.
Via Benzinga · April 3, 2025
Sarepta Plunges After EMA Puts Gene Therapy Studies On Hold Following Teen's Deathinvestors.com
The holds are temporary while the teenager's death is under investigation.
Via Investor's Business Daily · April 3, 2025
Will the Stock Market Crash or Soar in 2025? Wall Street Analysts Are Changing Their Forecasts.fool.com
Via The Motley Fool · April 3, 2025
Enphase Energy Stock Declines After Jefferies Cuts Price Target Amid Demand Concerns: Retail Remains Bearishstocktwits.com
The brokerage highlighted that the outlook for residential demand for Enphase’s products remains challenged due to worsening sentiment with respect to the Inflation Reduction Act.
Via Stocktwits · April 3, 2025
Tesla (NQ:TSLA) Stock Drops on Q1 Vehicle Delivery Miss
April 2, 2025 – Tesla, Inc. (NQ:TSLA) shares fell sharply in morning trading today after the electric vehicle giant reported first-quarter vehicle deliveries that significantly undershot Wall Street expectations. At 11:14:02 AM EDT, Tesla’s stock price stood at $265.62, reflecting a decline of $2.84, or
Via MarketMinute · April 2, 2025
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agenciesstocktwits.com
The sector's recent slide follows Peter Marks' resignation last week as the Food and Drug Administration's top vaccine regulator following a clash with Kennedy.
Via Stocktwits · April 2, 2025
Bloom Energy Rises After Power Supply Agreement With Conagra, Fuels Retail Optimismstocktwits.com
The company’s fuel cells would supply about 70% to 75% of the electricity needs at two Conagra facilities.
Via Stocktwits · April 2, 2025
Enphase Energy Stock Gains On Acquiring Over 2,500 SunPower Customers With Its Monitoring Services: Retail Remains Bearishstocktwits.com
Earlier, analysts at RBC Capital noted that while Enphase has a strong opportunity to return to growth eventually, in the near term, the company continues to cede market share amid softening demand.
Via Stocktwits · April 1, 2025
Biotech Stocks Take Another Beating As 'Chaos' Reigns At FDA With Reports Of Mass Firingsinvestors.com
Reports of mass firings include another high-profile official as Robert F. Kennedy Jr. and Marty Makary take up their new roles.
Via Investor's Business Daily · April 1, 2025